Translate This Page Print This Page Email a Friend Newsletter Sign-Up
Text Size : Sm Med Lg

Sample Image

Back to Health Topics A-Z Homepage
World TB Day 2006 Seminar

World TB Day is March 24. This annual event commemorates the date in 1882 when Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB).

In observance of World TB Day, the Bureau of TB Control (BTBC) hosted a Breakfast Seminar to launch the new TB Awareness Campaign and formally announce this year’s World TB Day theme, planned activities and the revival of the “Coalition for a TB-Free NYC” (formally known as the NYC TB Coalition Project). The Breakfast Seminar was held at the Nice Restaurant in the Chinatown area. Guests included local media, partners, providers and community based organizations serving high-risk communities.

Topics | Speakers Bios


TB Awareness Campaign in NYC MP3 Audio Presentation 
by Thomas R. Frieden, MD, MPH

Controlling Tuberculosis in the United States PDF Document (Reader Required) 
by Zachary Taylor, MD, MS

Working with Communities at Risk for Tuberculosis in New York City PDF Document (Reader Required) 
by Isaac Weisfuse, MD, MPH

A Case Study for TB/HIV Advocacy: The Local is Global PDF Document (Reader Required) 
by Javid Syed, MPH

The Benefits of the BTBC/BMS Collaboration
by Katherine A. Golar, MD

World TB Day 2006: From Data to Action PDF Document (Reader Required) 
by Sonal S. Munsiff, MD

Speakers Bios

Thomas R. Frieden, MD, MPH

Dr. Frieden is Commissioner of the New York City Department of Health and Mental Hygiene, one of the world’s oldest and largest public health agencies. Since becoming Commissioner in January 2002, Dr. Frieden has, among other initiatives, overseen the merger of NYC’s health and mental hygiene agencies, improving the coordination of mental and physical health promotion and protection; expanded data collection so that we know more than ever about the health status of New Yorkers; implemented a comprehensive tobacco control program that has resulted in nearly 200,000 fewer smokers and will prevent 60,000 premature deaths; established Take Care New York, a comprehensive health policy that targets the City’s most critical health problems; and opened community-based District Public Health Offices in Harlem, Central Brooklyn, and the South Bronx to improve health in the City’s sickest neighborhoods.

Dr. Frieden worked for the Centers for Disease Control and Prevention as an Epidemic Intelligence Service Officer in New York City from 1990-1992. From 1992-1996 he was Assistant Commissioner and Director of the Health Department’s tuberculosis control program. In this role, he managed the City’s successful tuberculosis control efforts, which reversed the epidemic of tuberculosis and multidrug-resistant tuberculosis. Dr. Frieden then worked in India for 5 years, helping the national government establish what is now the world’s largest effective tuberculosis program; India’s program has now treated millions of patients and saved hundreds of thousands of lives. Dr. Frieden completed his medical, public health, and internal medicine training at Columbia University and infectious disease training at Yale University; he has written more than 100 scientific articles.

Zachary Taylor, MD, MS

Dr. Zachary Taylor is the Chief of the Field Services and Evaluation Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC). Dr. Taylor has authored multiple peer reivewed journal articles and book chapters on TB control related issues. Most recently, Dr. Taylor was on the writing committee for new guidelines for the control of tuberculosis published jointly by the American Thoracic Society, CDC, and the Infectious Diseases Society of America.

Javid Syed

Javid Syed was born and raised in a Muslim family in Bombay, India and came to the U.S. in 1989. He did his BSc in Biology at Bowling Green, OH and his Masters in Public Health at Columbia University, New York.

Throughout his career Javid has linked community organizing, service provision, and research to inform his advocacy around issues of health and social justice. He has worked primarily in the specific context of Asian and Pacific Islander immigrant communities and through that connected with the broader issues of race, gender, sexuality, and class both within the US and transnationally. He has worked through multiple strategies of community organizing, service provision, policy advocacy and philanthropy to address the core issues that impact a community's access to health and wellness.

In 1993, when he moved to New York City, Javid worked at the Direct Observed Therapy clinic at Harlem Hospital while completing his Masters. There he developed a proposal that involved treatment education with DOT clients to involve them to become advocates for DOT in their peer community. The majority of the clients at the clinic were HIV positive.

For the last seven years Javid has worked on Asian and Pacific Islander immigrant HIV and AIDS issues in various capacities. From 1995-2000 he worked at the Asian and Pacific Islander Coalition on HIV/AIDS, New York. There he ran a prevention program, and organized a policy network of Asian and Pacific (A&PI) Islander service providers on the East Coast to bring visibility to immigrant HIV-related needs and advocate for increased resources for immigrant communities. The last four years Javid has worked at the Asian and Pacific Islander Wellness Center in San Francisco building the capacity of A&PI community members and service providers across the U.S. and it's affiliated Pacific Island Jurisdictions. The goal of this work was to enhance the community's ability to get involved in policy advocacy and adapt and tailor effective HIV interventions. He worked closely with a consortium of Gay Men of Color capacity builders to collaboratively address the issues of increasing sero-conversion amongst men who have sex with men (MSMs) and transgender women of color. Linked with the capacity building work, Javid has also overseen the implementation of research projects in partnership with Center for AIDS Prevention Studies focusing on A&PI prevention issues of HIV positive MSMs and HIV negative youth. He has presented talks about the HIV needs of A&PIs at various regional, national, and international forums.

Besides his health-focused work, Javid has also been providing leadership in queer people of color and arts organizing. He helped found the Audre Lorde Project, a center for community organizing for queer people of color in Brooklyn and is a funding panel member for Astraea Lesbian Foundation for Justice for their International Fund.

E-mail: Phone: (212) 253-7922

Sonal S. Munsiff, MD

Sonal S. Munsiff, M.D. has been the director of the New York City Tuberculosis (TB) Control Program since December 2000, and she is a Medical Officer in the Division of TB Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention since November 2001.

She is board certified in Internal Medicine and Infectious Diseases and has a broad range of experience in the field of TB. She has been with the TB Bureau since the height of the recent TB epidemic in New York City in 1992, initially as physician-in-charge at the Morrisania chest clinic, then medical consultant for Queens and Bronx regions, and from 1996 as Director of the Epidemiology Unit for the Bureau. She is quite familiar with the epidemiology and management of TB in the City in the past decade. She has written several papers on various aspects of TB epidemiology in NYC and has been a consultant for the CDC on several TB statements.

As the Director, she is responsible for directing the multifaceted activities of the largest TB program in the country and providing medical supervision to 10 chest clinics located throughout the city. Dr. Munsiff is interested in further developing research in the epidemiology and treatment of drug-resistant TB, clinical aspects of TB in HIV-infected persons, the global epidemiology of TB particularly as it affects the TB incidence in New York City, program evaluation, and the challenges of identifying and treating persons with latent TB infection who are at high risk of developing disease.